behavioral disorders and psychotropic medications tintinalli chapters 288, 289, 290

72
Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Upload: diana-hill

Post on 28-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disordersand

Psychotropic Medications

Tintinalli Chapters 288, 289, 290

Page 2: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Epidemiology

Up to 1/3 of ER Population Most recognized prevalent ED psychiatric

illnesses:• Substance abuse• Anxiety disorders• Severe cognitive impairment• Psychosis• Antisocial personality disorder• Mood disorders

Schizophrenia overrepresented due to multiple visits

Page 3: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Diagnosis

Most important, is the patient a threat to himself or others?

Treat the symptoms, then focus on the major complaint

Specific diagnosis is not essential Need to be familiar with behavioral

disorders to communicate effectively with other health care professionals

Page 4: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Multiaxial Diagnostic System from

DSM-IV TR – 2000 Axis I – Mental disorders Axis II – Personality/Developmental

disorders Axis III – Medical disorders Axis IV – Psychosocial and

environmental disorders Axis V – Global functioning

Page 5: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders – Psychiatric Syndromes

Delirium, dementia, cognitive disorders Mental disorders due to medical condition Substance induced disorders Schizophrenia and other psychotic disorders Mood, anxiety and somatoform disorders Factitious, dissociative, eating and adjustment

disorders

Page 6: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Dementia: pervasive disturbance of cognitive function with normal consciousness in several areas

Delirium: Disturbance in cognitive function with clouding of consciousness and decreased environmental awareness

• Acute onset• Rapidly alternating in severity• Hallucinations common

Substance induced• Acute Intoxication – alcohol, amphetamines• Withdrawal - alcohol

Page 7: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Disorders due to Medical Condition• Thyroid, cancer, diabetes, HIV, etc…• Schizophrenia and other Psychotic

Disorders• Deterioration in function characterized by

• Hallucinations• Delusions• Disorganized speech• Disorganized behavior• Catatonic behavior

Page 8: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral DisordersSchizophrenia and other Psychotic

DisordersNegative Symptoms

• Blunted affect• Emotional withdrawal• Lack of spontaneity• Anhedonia• Attention impairment

• Persecutory, Grandiose, Bizarre –delusion types • Schizophreniform disorder – schizophrenia less

than 6 months

Page 9: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Mood Disorders

Major Depression• Persistent depressed mood with loss of

interest in usual activities for more than two weeks

• Female > Male• IN SAD CAGES - Mnemonic

Page 10: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Bipolar disorder• Onset 3rd to 4th decades• Mania cycling with major depression with periods of

normal behavior• Depressive episodes more frequent than manic• Complications: substance abuse, marital and job

problems, trauma, suicide – problems related to manic episodes

Dysthymic Disorder• Mild depression >2 years duration

Page 11: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Anxiety Disorders• 4-8% of population, may be higher in ED – perceived

physical complaints• Apprehension, fears and excessive worry with

autonomic features• Subtypes:

• Panic disorder• Generalized anxiety disorder• Phobic disorder • Post-traumatic stress disorder• Obsessive-compulsive disorder

Page 12: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Somatoform Disorder• Physical complaints or symptoms without any

identifiable medical explanation• Conversion disorder-loss of function after

psychological trauma• Somatization disorder-wide variety of complaints

with no apparent medical cause - caution making this diagnosis in ED

• Hypochondriasis - preoccupation with fear of serious illness despite appropriate medical evaluation

• P.G. for those who have worked at Doctors, 156 visits last year

Page 13: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis I Disorders

Dissociative Disorder• Alteration in normal integration of identity

and consciousness• Psychogenic amnesia-loss of memory for

important personal details• Psychogenic fugue-loss of memory and

assumption of new identity

Page 14: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders

Axis II Disorders – Personality Disorders Lifelong pattern of behavior causing

impairment in social or occupational functioning or causing considerable distress, unrelated to periods of illness

Most are unaware of their behavior and if become aware are unlikely to change

Page 15: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders Axis II Disorders - Personality Disorders

Classifications – Table 288-3• Antisocial• Narcissistic• Paranoid• Obsessive-Compulsive• Dependent• Schizoid• Histrionic• Schizotypal• Borderline• Avoidant

Page 16: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Psychiatric Emergencies

The acutely psychotic, suicidal or violent patient Often present when lack of behavioral health

resources - nights, weekends ED Psychiatric Assessment

• Is the patient stable or unstable?• Does the patient have a serious medical condition that

is causing the abnormal behavior?• Is the cause psychiatric or functional?• Is psychiatric consultation necessary?• Should the patient be forcibly detained for evaluation?

Page 17: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Safety

Violent patient – immediate restraint Security and police are best trained Violent or potentially violent should be

disrobed and searched for weapons that can be used towards staff or the patient

Use non-threatening or non-judgmental tone – don’t make direct eye contact, submissive tone and posture

Allow room for escape – don’t let patient get between you and the door

Page 18: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment History

Change in behavior – confirmed by family if possible

Medical symptoms – rule out medical cause Medical conditions Medication history – prescription & OTC Social history, alcohol, stressors – illicit drugs Family history of psychiatric illnesses Question family and friends

Page 19: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Mental Status Examination

Psychiatric or medical disorder MMSE – Table 289-1

• Behavior• Affect• Language• Judgment• Orientation• Memory• Thought content• Perceptual abnormalities

Page 20: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Physical Exam

Identify medical problems that may be causing behavior

Examine for evidence of trauma Caution with

• Abnormal mental status• Psychosis• Mental retardation• Elderly

Page 21: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Laboratory

Urine toxicology Urine pregnancy Salicylate, APAP Blood alcohol ECG Accucheck/Electrolytes

Consultation Potential for suicidal or homicidal actions or

psychotic Don’t ignore abnormal vital signs

Page 22: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Suicide

Major cause of death, especially the young Suicide Characteristics (more common in

suicide completers): older, male, lives alone or are physically ill

High risk psychiatric illnesses: Schizophrenia, substance abuse and major depression

Suicide attempts:• Drug overdose in large majority• Violent attempt (shooting, hanging, jumping) more

likely to succeed and much more likely to try again if unsuccessful

Page 23: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment

Divorced Unemployed Male Non-religious Socially isolated Suicidal ideation

Physical illness Social/Family

structure loss Mental illness Suicidal attempts

• Repeated attempts• Realistic plan• Continuing

thoughts of death

•High Risk of Potential Suicide

Page 24: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Disposition

Usually determined in conjunction with mental health professional

Criteria for discharge• Medically stable• Must not be intoxicated, delirious or demented• Treatment has been arranged• Precipitants to crisis have been addressed and

reduced• Must not be imminently suicidal• Lethal means of self-harm removed• Agrees to return to ED if suicidal intent recurs

Page 25: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Behavioral Disorders:Emergency Assessment Disposition

Criteria for Discharge• Physician believes patient will follow

through with treatment plan• Caregivers and social supports (family) in

agreement with discharge and treatment plan

If these cannot be assured, admission Contracting for safety?

Page 26: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Psychotropic Medications

Page 27: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Psychotropic Meds Be familiar with emergency indications,

side effects, adverse reactions, and common interactions

4 Classes Antipsychotics Anxiolytics Antidepressants Mood stabilizers, including anticonvulsants

Antipsychotics and anxiolytics have the most desired emergency utility

Page 28: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics (Neuroleptics) These meds are symptom specific,

not disease specific They are useful for nearly all

psychoses: Primary (a result of psychiatric illness) Secondary (substance induced or from

general medical condition)

Page 29: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics In ED, most often used to control

agitated or psychotic behavior that constitutes immediate danger to self or others

Contraindications – known allergy to the med or another drug in the same class

Page 30: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics Low potency antipsychotics

(Thorazine) are rarely used due to significant hypotension side effect – rarely indicated in ED

High potency meds (Haldol) are safe even at high doses. They have few anticholinergic and alpha-blocking effects

Page 31: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Haldol IV Haldol is not approved by FDA, but IV

route has less extrapyramidal side effects than IM or oral routes, onset 10-20mins

Do not give Haldol to pts with Parkinsons disease Movement disorders Anticholinergic toxicity PCP toxicity Pregnancy

Initial starting does 1-5 mg

Page 32: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Haldol Max effective dose of Haldol is 10mg.

Doses greater than 10mg only increases side effects and does not improve effectiveness or relief of symptoms If need for increased relaxation add Ativan

Lower the initial dose in elderly, debilitated, brain injured, or those with AIDS

Page 33: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Haldol To obtain rapid tranquilization, use

Haldol with Ativan (2mg) effect. Initial Haldol dose is usually 2-5 mg

IM. May repeat in 30-45 minutes. Six doses max, in 24 hours.

Page 34: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Acute Distonia: Muscle spasms of

the neck, face, and back Most common side effect of

antipsychotic meds Less common: oculogyric crisis and

laryngospasm Diphenhydramine can also be used,

50-100 mg IV.

Page 35: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Akathisia: a sensation of motor

restlessness with a subjective desire to move.

Can begin anytime after medication is started.

Worsened with increasing doses. Treat with beta-blockers and lower the

dose. Cogentin and Benzodiazepines also

effective

Page 36: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Parkinson Syndrome

Extrapyramidal Symptoms• Bradykinesia• Resting tremor• Cogwheel rigidity• Shuffling gait• Masked facies• Drooling

• Often only one or two features are obvious

Usually begins in the first month of treatment. Treat by lowering dosage and/or using

anticholinergics

Page 37: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Anticholinergic Effects: range from

mild sedation to delirium, dry mouth, blurred vision, urinary retention, constipation, and paralytic ileus.

Treat by stopping the antipsychotic and institute supportive measures as needed.

Page 38: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Cardiovascular Effects: Include QT

prolongment, orthostatic hypotension, cardiovascular collapse QT prolongation Orthostatic hypotension

• Neg. inotropic effect on heart and alpha adrengergic blockade.

Treat with IVFs and vasopressor support. Almost exclusively seen with the low

potency meds, although high doses of Haldol can cause torsades

Page 39: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antipsychotics – Side Effects Neuroleptic Malignant Syndrome: Idiosyncratic

reaction manifested by rigidity, fever, autonomic instability (tachycardia, diaphoresis, and BP abnormalities) and a confusion state. Flushing Fever High CPR in thousands Leukocytosis ? LF shift

Mortality rate of 20% Treat by stopping medication, IVFs, ICU

support, and possibly dantrolene and valium

Page 40: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Atypical Antipsychotic Agents Clozapine

Used in schizophrenia unresponsive to standard agents

Can cause: agranulocytosis, seizures, and respiratory depression

Risperdone Probably safer than Clozapine IM formulation for ED use 2nd line agent

Page 41: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Atypical Antipsychotic Agents Olanzapine

Similar to Risperdone 2nd line agent

Ziprasidine Profile similar to Risperdone Waiting for studies to show

effectiveness Questionable ability to titrate

Page 42: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics Short term anxiolytic therapy may be

helpful in the anxious, agitated patient during a crisis.

Useful in acute stressful situations unresponsive to reassurance.

Benzodiazepines are contraindicated in acute narrow-angle glaucoma.

Pregnancy is a relative contraindication.

Page 43: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics Rule out any serious underlying

psychiatric illness, of which anxiety is a symptom.

Benzos are very effective anxiolytics with a high therapeutic index.

Non-benzos have much lower therapeutic indices and high addictive potential Barbiturates

Page 44: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics With all Benzos, adjust dosage as necessary

Xanax Ativan Valium Versed Librium

Higher dosages may be needed in pts. with history of alcohol abuse or sedative use.

Decrease dose in those with hepatic disease or severe debilitation.

Page 45: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics Benzos potentiate other CNS

depressants, so use with extreme caution with intoxicated pts.

Careful in pts with hypercarbia because they suppress hypoxic respiratory drive.

Caution with CO2 retainers (COPD)

Page 46: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics – Side Effects Benzos side effects are usually mild

Drowsiness, decreased alertness, sedation and ataxia are the most common.

Decrease dose to treat. If severe, give flumazenil 0.2mg IV over

15-30 seconds and then 0.2 to 0.4mg q 30-60 seconds up to 3mg total. Careful of withdrawal symptoms Go very slow – 0.2 increments

Page 47: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anxiolytics – Side Effects Don’t give flumazenil in chronic

benzo use. Can induce seizures.

Never prescribe more than week’s worth of benzos due to abuse potential.

Page 48: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants Previously Tricyclics, now called Hetero-

cyclics (HCA’s). Indications:

Major depression Dysthymic disorder Panic disorder Agoraphobia OCD Enuresis School phobia.

Page 49: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants – Side Effects HCA’s have low therapeutic indices. Most

side effects are anticholinergic or cardiotoxic Side effects can occur even at therapeutic

doses. Anticholinergic Effects: Most common,

with other meds with anticholinergic effects: low potency antipsychotics, antiparkinsonian agents, and antihistamines

Page 50: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants – Side Effects Peripheral effects

Dry mouth Metallic taste Blurred vision Constipation Paralytic ileus Urinary retention Tachycardia Exacerbation of narrow angle glaucoma

Page 51: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants – Side Effects Central effects

Sedation Mydriasis Agitation Delirium

Page 52: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants – Side Effects Mild to moderate effects may be

managed by dose reduction, changing to a med with fewer anticholinergic properties Urecholine 10-25 mg tid.

Acute urinary retention: Urecholine 2.5-5 mg SC.

Page 53: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Antidepressants – Side Effects Cardiovascular Effects:

Non-specific T-wave changes Prolonged QT interval Varying degrees of AV block Atrial and ventricular dysrhythmias.

Orthostatic hypotension especially significant in the elderly, due to alpha-adrenergic blockade.

Page 54: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Monoamine Oxidase Inhibitors Therapeutic effects due to their ability to

increase norepinephrine and serotonin in the CNS.

Indications: Atypical severe depressive episodes,

characterized by hyperphagia, hypersomnolence, reversed diurnal variation (symptoms worse at night), emotional lability, “leaden” paralysis (heavy arms or legs) and rejection hypersensitivity.

Page 55: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

MAOIs – Side Effects Fewer side effects than HCA’s. Orthostatic hypotension, can be

severe, usually responds to supportive therapy.

CNS irritability (agitation, motor restlessness, insomnia) managed by dose reduction or addition of benzodiazepine.

Page 56: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

MAOIs – Side Effects Autonomic side effects

Dry mouth Constipation Urinary retention Delayed ejaculation

MAOIs block oxidative deamination of tyramine. May precipitate a hypertensive crisis when certain drugs or tyramine containing foods are ingested.

Page 57: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

MAOIs – Side Effects Tyramine containing foods:

beer wine aged cheese chopped liver sour cream yogurt pickled herring.

Symptoms include headache, HTN, cardiac dysrhythmias, restlessness, diaphoresis, mydriasis, and vomiting.

Phentolamine – antidote for malignant HTN

Page 58: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

MAOIs Do not treat with beta blockers -

may intensify vasoconstriction and worsen HTN.

Most patients recover completely within a few hours.

Page 59: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Selective Serotonin Reuptake Inhibitors SSRIs are the most commonly prescribed anti-

depressants Indicated for treatment of major depressive

episodes but also used for dysthymia and generalized anxiety disorders, panic disorders, and OCD.

Sertraline Paroxetine Flavoxamine Citalopram Escitalopram

Page 60: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

SSRIs Favorable side effect profile and

relative safety in overdose. They have a high therapeutic index Lack anticholinergic and cardiac

effects like HCA’s.

Page 61: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

SSRIs – Side Effects Most common

HA Dizziness Sexual dysfunction Nausea Diarrhea Insomnia Agitation

Less common Akathisia Apathy syndrome

Page 62: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

SSRIs – Side Effects Discontinuation syndrome occurs especially with

agents having shorter lives, Sertraline and Paroxetine

Typically presents several days after cessation: Flu-like syndrome Nausea Vomiting Fatigue Myalgias Vertigo HA Insomnia Paresthesias

Page 63: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

SSRIs – Side Effects Treat by reinstating SSRI therapy

and taper more gradually.

Page 64: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

SSRIs – Serotonin Syndrome Serotonin Syndrome: occurs when

combining SSRIs with other serotonergic meds - MAOIs, HCAs, other SSRIs.

Syndrome presents as restlessness, tremor, myoclonus, hyperreflexia, seizures, and N/V/D.

Treat by stopping serotonergic agents and supportive care.

Page 65: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Mood Stabilizers Lithium has been mainstay of bipolar

treatment for years. Anticonvulsants (Tegretol, Depakote,

Lamictal, Topamax) are being used increasingly in management.

Page 66: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Mood Stabilizers - Lithium Indicated for both acute mania and

maintenance therapy in bipolar disorder.

Useful in some cases of major depression, and in some disorders characterized by episodic explosive outbursts or self-mutilation.

Page 67: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Lithium: Side Effects Most serious side effects are due to toxic

serum levels. Mild side effects

GI distress Dry mouth Excessive thirst Fine tremors Mild polyuria Peripheral edema

Most common during first few weeks of therapy and with therapeutic levels.

Page 68: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Lithium: Side Effects Chronic side effects are unrelated to

lithium levels and include Polyuria Nephrogenic diabetes insipidus Benign diffuse goiter Hypothyroidism Skin rasher Ulcerations Psoriasis Leukocytosis without left shift

Page 69: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Lithium: Toxicity Severity of toxicity is related to the

serum lithium level and duration of elevation.

Even in acute OD, symptoms may be delayed up to 48 hours.

Signs of toxicity include N/V, dysartheria , lethargy, and hand tremor.

Page 70: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Lithium: Toxicity As toxicity worsens

Ataxia Myasthenia Incoordination Hyperreflexia Muscle fasiculations Blurred vision Scotoma Coma

Page 71: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Lithium: Toxicity Cardiovascular symptoms:

Nonspecific T-wave changes Hypotension AV conduction defects Ventricular tachydysrhythmias Vascular collapse.

Lithium toxicity may result in permanent neurologic impairment

Page 72: Behavioral Disorders and Psychotropic Medications Tintinalli Chapters 288, 289, 290

Anticonvulsants Work through different mechanisms

to cause neuronal relaxation. Used with rapid cycling, cyclothymic

and mixed states of bipolar illness. Other uses:

Impulsive aggression Behavioral disturbances Self-injurious behavior